Figure 1.
New therapeutic targets in β-thalassemias: (A,D) impaired α:β-globin ratio, (B) ineffective erythropoiesis, and (C) iron metabolism and hemolysis. TMPRSS6, transmembrane protease serine 6.
New therapeutic targets in β-thalassemias: (A,D) impaired α:β-globin ratio, (B) ineffective erythropoiesis, and (C) iron metabolism and hemolysis. TMPRSS6, transmembrane protease serine 6.
